Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this clinical research study is to evaluate the safety and efficacy
of ReFacto in subjects with hemophilia A undergoing major surgery monitored using the
chromogenic substrate assay at the local laboratory.